BioSpace News Archive

Digital Value-Added Medicines, waste management and the use of blockchain identified as key trends for the upcoming year

Syndivia receives the exclusive license from SATT Conectus to DARx technology, which allows them to generate monodisperse 1-to-1 conjugates starting from off the shelf protein substrates.

The Company and its wholly owned subsidiary, Motif BioSciences Inc., have entered into a loan Amendment and Release agreement with Hercules Capital Inc., the senior secured lender to Motif Inc, regarding certain actions which fully satisfy the conditions attached to the Company’s previously announced agreement in principle with Hercules

Souderton, PA, U.S., 28 January 2020 – Almac Clinical Services, part of the global contract pharmaceutical development and manufacturing organization the Almac Group, is delighted to invite participants from the Pharma & Biotech industries to join its West Coast Lunch and Learn Workshop Series.

The focus of the research will be to learn more about ApoE4 and how and why it affects Alzheimer’s disease.

In its annual report, Novartis said it has stopped working on the years-long project and will record a $442 million impairment charge as a result.

“In 2019 Biogen demonstrated strong execution across all of our core business areas with resilience in MS, continued strong worldwide growth for Spinraza, and an expanded biosimilars business,” noted Michel Vounatsos, Biogen’s chief executive officer.

David Ricks, chairman and chief executive officer of Eli Lilly, said the company is in an exciting period of growth.

As you build your career strategy, one thing to keep in mind is how you want to be remembered. What do you want to be known for? Answer this question as you map out your goals.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.